Phase II Preview For Roche's Dalcetrapib May Give CETP Inhibition A Boost
European Society of Cardiology Congress abstract for small study suggests Roche's dalcetrapib is safe and works on plaque burden.
European Society of Cardiology Congress abstract for small study suggests Roche's dalcetrapib is safe and works on plaque burden.